If there was no report of the adverse reaction in the progress notes, the provider was contacted to determine whether he or she knew about the reaction. If not, we then asked the provider if any ...
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting
Diagnostic radiopharmaceuticals, including PYLARIFY ... The effect of these therapies on performance of PYLARIFY PET has not been established. To report suspected adverse reactions for PYLARIFY, call ...
The detection of adverse drug reactions (ADRs) by a traditional passive reporting system and by a method involving patient and provider interviews was studied. The study sample consisted of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback